https://ift.tt/2IVHF6y

The stock hit a new high of Rs 718, rallying 8% in two days after the company's drug substance manufacturing site at Bengaluru campus by the US health regulator has concluded without any observations.

from Markets https://ift.tt/2xGA0kO

Comments

Popular posts from this blog

CAG flags tax irregularities by banks, NBFCs

Locust control eligible for SDRF and NDRF relief

IIT PhDs in demand for high-end R&D jobs